Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients

NCT05673798 is registered in ClinicalTrials.gov with The Second Hospital of Shandong University as lead sponsor.

NCT NCT05673798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05673798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients
Lead sponsor
The Second Hospital of Shandong University
Phase
Observational
Overall status
Completed
Start date
September 1, 2016
Completion date
November 30, 2022
Enrollment
569 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer